Activation of purified soluble guanylate cyclase by protoporphyrin IX.

PubWeight™: 1.64‹?› | Rank: Top 3%

🔗 View Article (PMC 346308)

Published in Proc Natl Acad Sci U S A on May 01, 1982

Authors

L J Ignarro, K S Wood, M S Wolin

Articles citing this

cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev (2010) 3.27

Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci (2008) 3.08

Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc Natl Acad Sci U S A (1993) 2.94

NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov (2006) 2.84

Crystal structure of an oxygen-binding heme domain related to soluble guanylate cyclases. Proc Natl Acad Sci U S A (2004) 2.41

Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J (1996) 2.13

A molecular basis for nitric oxide sensing by soluble guanylate cyclase. Proc Natl Acad Sci U S A (1999) 1.86

Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase. Proc Natl Acad Sci U S A (1994) 1.58

NO activation of guanylyl cyclase. EMBO J (2004) 1.50

CO-sensing mechanisms. Microbiol Mol Biol Rev (2004) 1.30

On the activation of soluble guanylyl cyclase by nitric oxide. Proc Natl Acad Sci U S A (2001) 1.12

Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation. Br J Pharmacol (2009) 1.06

The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: interactions at ferrous heme and cysteine thiols. J Biol Chem (2009) 1.05

Acute blood pressure effects of YC-1-induced activation of soluble guanylyl cyclase in normotensive and hypertensive rats. Br J Pharmacol (2000) 1.04

A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases. Handb Exp Pharmacol (2009) 0.95

Heme-dependent and independent soluble guanylate cyclase activators and vasodilation. J Cardiovasc Pharmacol (2010) 0.91

Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management. Am J Physiol Renal Physiol (2012) 0.87

Identification of residues in the heme domain of soluble guanylyl cyclase that are important for basal and stimulated catalytic activity. PLoS One (2011) 0.87

Aspartate 102 in the heme domain of soluble guanylyl cyclase has a key role in NO activation. Biochemistry (2011) 0.87

High-Throughput Screening to Identify Compounds That Increase Fragile X Mental Retardation Protein Expression in Neural Stem Cells Differentiated From Fragile X Syndrome Patient-Derived Induced Pluripotent Stem Cells. Stem Cells Transl Med (2015) 0.87

Modulation of the NO trans effect in heme proteins: implications for the activation of soluble guanylate cyclase. J Biol Inorg Chem (2003) 0.86

Iron-based redox switches in biology. Antioxid Redox Signal (2009) 0.85

A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction. Adv Pharmacol Sci (2010) 0.83

Regulation of activity of purified guanylate cyclase from liver that is unresponsive to nitric oxide. Biochem J (1983) 0.82

Oxygen binding and redox properties of the heme in soluble guanylate cyclase: implications for the mechanism of ligand discrimination. J Biol Chem (2011) 0.81

Exposure of mice to chronic hypoxia attenuates pulmonary arterial contractile responses to acute hypoxia by increases in extracellular hydrogen peroxide. Am J Physiol Regul Integr Comp Physiol (2014) 0.80

Intracellular nitric oxide mediates neuroproliferative effect of neuropeptide y on postnatal hippocampal precursor cells. J Biol Chem (2012) 0.79

Elevation of soluble guanylate cyclase suppresses proliferation and survival of human breast cancer cells. PLoS One (2015) 0.78

The link between unpredictable chronic mild stress model for depression and vascular inflammation? Inflammation (2014) 0.77

Targeting soluble guanylate cyclase for the treatment of pulmonary hypertension. Expert Rev Respir Med (2011) 0.77

Contemporary Approaches to Modulating the Nitric Oxide-cGMP Pathway in Cardiovascular Disease. Circ Res (2017) 0.76

Integrative Signaling Networks of Membrane Guanylate Cyclases: Biochemistry and Physiology. Front Mol Neurosci (2016) 0.76

Protoporphyrin IX/Cobyrinate Derived Hybrids - Novel Activators of Soluble Guanylyl Cyclase. European J Org Chem (2013) 0.75

Relaxation of rat vascular muscle by peripheral benzodiazepine modulators. J Clin Invest (1989) 0.75

Attenuation of nitric oxide-stimulated soluble guanylyl cyclase from the rat brain by halogenated volatile anesthetics. J Anesth (1998) 0.75

Articles cited by this

Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther (1981) 6.71

Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A (1977) 4.90

Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharmacol Exp Ther (1981) 3.14

Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Res (1979) 3.11

Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood (1981) 2.93

Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens. Nature (1977) 2.15

Regulation of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate levels and contractility in bovine tracheal smooth muscle. Mol Pharmacol (1977) 1.98

Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle. Naunyn Schmiedebergs Arch Pharmacol (1979) 1.95

Activation of guanylate cyclase from rat liver and other tissues by sodium azide. J Biol Chem (1975) 1.77

Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation. J Biol Chem (1978) 1.72

Soluble guanylate cyclase purified from bovine lung contains heme and copper. FEBS Lett (1981) 1.55

Inhibition of platelet function by organic nitrate vasodilators. Blood (1980) 1.35

Purification of a soluble, sodium-nitroprusside-stimulated guanylate cyclase from bovine lung. Eur J Biochem (1981) 1.28

Electron paramagnetic resonance studies of nitrosyl ferrous heme complexes. Determination of an equilibrium between two conformations. J Biol Chem (1980) 1.28

Increases in cyclic GMP levels in brain and liver with sodium azide an activator of guanylate cyclase. Nature (1975) 1.17

Calcium-independent modulation of cyclic GMP and activation of guanylate cyclase by nitrosamines. Science (1976) 1.13

Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP formation in smooth muscle and platelets. Adv Cyclic Nucleotide Res (1978) 1.12

Effects of stimulant and relaxant drugs on tension and cyclic nucleotide levels in canine femoral artery. Mol Pharmacol (1976) 1.11

Purification of soluble guanylate cyclase from rat lung. J Biol Chem (1979) 1.08

Purification of soluble guanylate cyclase from rat liver. Proc Natl Acad Sci U S A (1979) 1.06

Evidence that regulation of hepatic guanylate cyclase activity involves interactions between catalytic site -SH groups and both substrate and activator. Arch Biochem Biophys (1981) 1.01

Electron paramagnetic resonance of nitric oxide--protoheme complexes with some nitrogenous base. Model systems of nitric oxide hemoproteins. Biochemistry (1969) 0.95

Platelet inhibition by sodium nitroprusside, a smooth muscle inhibitor. Blood (1976) 0.92

Activation of hepatic guanylate cyclase by N-methyl-N'-nitro-N-nitrosoguanidine. Effects of thiols, N-ethylmaleimide, and divalent cations. J Biol Chem (1977) 0.85

Guanylate cyclase: purification, properties, free radical activation, radiolabeling, and preparation of hybridoma antibodies. Adv Cyclic Nucleotide Res (1981) 0.82

Selective alterations in responsiveness of guanylate cyclase to activation by nitroso compounds during enzyme purification. Biochim Biophys Acta (1981) 0.81

Na-nitroprussid. A very potent platelet desaggregating substance. Acta Univ Carol Med Monogr (1972) 0.79

Structural basis for the conformational states of nitrosyl hemoglobins M Saskatoon and M Milwaukee. Influence of distal histidine residues on proximal histidine-iron bonds. J Biol Chem (1980) 0.78

Articles by these authors

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A (1987) 14.22

Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther (1981) 6.71

Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res (1987) 4.42

The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol (1985) 3.29

Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharmacol Exp Ther (1981) 3.14

Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood (1981) 2.93

Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. J Pharmacol Exp Ther (1986) 2.64

Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol (1995) 2.60

Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med (1992) 2.56

Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun (1990) 2.55

Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol (1993) 2.53

Periodic emission from the gamma-ray binary 1FGL J1018.6-5856. Science (2012) 2.40

NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol (1994) 2.21

Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochim Biophys Acta (1982) 2.00

Stretch-induced programmed myocyte cell death. J Clin Invest (1995) 1.99

Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-deficient enzyme forms. J Biol Chem (1986) 1.86

Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery. J Pharmacol Exp Ther (1984) 1.85

Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension (1991) 1.77

Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res (1995) 1.76

Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. Can J Physiol Pharmacol (1981) 1.74

Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols. Biochim Biophys Acta (1980) 1.74

Detection of 16 gamma-ray pulsars through blind frequency searches using the Fermi LAT. Science (2009) 1.74

Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Am J Physiol (1987) 1.72

Formation of free nitric oxide from l-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase. Proc Natl Acad Sci U S A (1994) 1.71

Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. Mol Pharmacol (1983) 1.68

IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells. Am J Physiol Cell Physiol (2000) 1.67

Bioregulation of lysosomal enzyme secretion from human neutrophils: roles of guanosine 3':5'-monophosphate and calcium in stimulus-secretion coupling. Proc Natl Acad Sci U S A (1975) 1.65

Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation. J Pharmacol Exp Ther (1988) 1.58

Hormonal control of lysosomal enzyme release from human neutrophils. Effects of autonomic agents on enzyme release, phagocytosis, and cylic nucleotide levels. J Exp Med (1974) 1.58

Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation. Proc Natl Acad Sci U S A (2001) 1.58

Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res (1994) 1.57

Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem Biophys Res Commun (1995) 1.57

Nitric oxide and atherosclerosis. Nitric Oxide (2001) 1.57

ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation (1997) 1.56

Modulated high-energy gamma-ray emission from the microquasar Cygnus X-3. Science (2009) 1.55

Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. J Biol Chem (1984) 1.55

The imprint of the extragalactic background light in the gamma-ray spectra of blazars. Science (2012) 1.53

Arginase activity in endothelial cells: inhibition by NG-hydroxy-L-arginine during high-output NO production. Am J Physiol (1996) 1.50

Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from L-arginine. Biochem Biophys Res Commun (1992) 1.50

Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res (1993) 1.48

Hormonal control of lysosomal enzyme release from human neutrophils: elevation of cyclic nucleotide levels by autonomic neurohormones. Proc Natl Acad Sci U S A (1974) 1.48

Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem Biophys Res Commun (1992) 1.46

Sites of superoxide anion production detected by lucigenin in calf pulmonary artery smooth muscle. Am J Physiol (1994) 1.45

Conversion of nitroxyl (HNO) to nitric oxide (NO) in biological systems: the role of physiological oxidants and relevance to the biological activity of HNO. Biochem Biophys Res Commun (1993) 1.44

Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol (1992) 1.41

Vascular smooth muscle-derived relaxing factor (MDRF) and its close similarity to nitric oxide. Biochem Biophys Res Commun (1990) 1.41

Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc Natl Acad Sci U S A (2001) 1.39

The Fermi Gamma-Ray Space Telescope discovers the pulsar in the young galactic supernova remnant CTA 1. Science (2008) 1.39

A cocoon of freshly accelerated cosmic rays detected by Fermi in the Cygnus superbubble. Science (2011) 1.39

Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci U S A (1992) 1.39

Purification and properties of heme-deficient hepatic soluble guanylate cyclase: effects of heme and other factors on enzyme activation by NO, NO-heme, and protoporphyrin IX. Arch Biochem Biophys (1982) 1.38

Fermi observations of high-energy gamma-ray emission from GRB 080916C. Science (2009) 1.37

Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience (1994) 1.36

Properties of a superoxide anion-generating microsomal NADH oxidoreductase, a potential pulmonary artery PO2 sensor. Am J Physiol (1994) 1.36

Possible involvement of S-nitrosothiols in the activation of guanylate cyclase by nitroso compounds. FEBS Lett (1980) 1.36

Enzyme release from polymorphonuclear leukocyte lysosomes: regulation by autonomic drugs and cyclic nucleotides. Science (1973) 1.34

Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B. Proc Natl Acad Sci U S A (1996) 1.32

Coronary arterial relaxation and guanylate cyclase activation by cigarette smoke, N'-nitrosonornicotine and nitric oxide. J Pharmacol Exp Ther (1980) 1.31

Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J Immunol (1993) 1.30

Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation. Biochem Biophys Res Commun (1989) 1.29

Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem Biophys Res Commun (1993) 1.29

A spectrophotometric assay for nitrate using NADPH oxidation by Aspergillus nitrate reductase. Anal Biochem (1993) 1.29

Endothelium-derived nitric oxide relaxes nonvascular smooth muscle. Eur J Pharmacol (1989) 1.27

Nonphagocytic release of neutral protease and beta-glucuronidase from human neutrophils. Regulation by autonomic neurohormones and cyclic nucleotides. Arthritis Rheum (1974) 1.27

Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation (1995) 1.26

A population of gamma-ray millisecond pulsars seen with the Fermi Large Area Telescope. Science (2009) 1.24

Nitric oxide. An important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation (1995) 1.24

Nitric oxide-cyclic GMP signal transduction system. Methods Enzymol (1996) 1.23

Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP. J Pharmacol Exp Ther (1984) 1.23

Superoxide anion inhibits cGMP-associated bovine pulmonary arterial relaxation. Am J Physiol (1990) 1.23

Lipopolysaccharide-induced expression of interferon-beta mediates the timing of inducible nitric-oxide synthase induction in RAW 264.7 macrophages. J Biol Chem (2001) 1.22

Differences in responsiveness of intrapulmonary artery and vein to arachidonic acid: mechanism of arterial relaxation involves cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate. J Pharmacol Exp Ther (1985) 1.20

A limit on the variation of the speed of light arising from quantum gravity effects. Nature (2009) 1.20

Vicinal nitrohydroxyeicosatrienoic acids: vasodilator lipids formed by reaction of nitrogen dioxide with arachidonic acid. J Pharmacol Exp Ther (2001) 1.19

H2O2 and cGMP may function as an O2 sensor in the pulmonary artery. J Appl Physiol (1985) (1989) 1.19

Breakdown of noncollagenous chondromucoprotein matrix by leukocyte lysosome granule lysates from guinea pig, rabbit, and human. Clin Immunol Immunopathol (1973) 1.18

NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein. Proc Natl Acad Sci U S A (1990) 1.17

Neutral protease release from human leukocytes regulated by neurohormones and cyclic nucleotides. Nat New Biol (1973) 1.16

Role of endothelium-derived prostaglandins in hypoxia-elicited arteriolar dilation in rat skeletal muscle. Circ Res (1992) 1.16

Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc Natl Acad Sci U S A (1999) 1.16

Chronic exercise enhances endothelium-mediated dilation of epicardial coronary artery in conscious dogs. Circ Res (1993) 1.16

Inhibition of coronary artery superoxide dismutase attenuates endothelium-dependent and -independent nitrovasodilator relaxation. Circ Res (1991) 1.16

Mediation of immunologic discharge of lysosomal enzymes from human neutrophils by guanosine 3',5'-monophosphate. Requirement of calcium, and inhibition by adenosine 3',5'-monophosphate. J Exp Med (1974) 1.15

An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity. Proc Natl Acad Sci U S A (2001) 1.14

Neuronal nitric oxide synthase self-inactivates by forming a ferrous-nitrosyl complex during aerobic catalysis. J Biol Chem (1995) 1.13

Guanylate cyclase from bovine lung. A kinetic analysis of the regulation of the purified soluble enzyme by protoporphyrin IX, heme, and nitrosyl-heme. J Biol Chem (1982) 1.12

Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure. Circ Res (1996) 1.12